DEUTSCHE BANK AG\ - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$21,000
-80.9%
32,308
-76.3%
0.00%
Q1 2019$110,000
-51.8%
136,225
-5.2%
0.00%
Q4 2018$228,000
-84.4%
143,623
-67.6%
0.00%
Q3 2018$1,465,000
+82.2%
443,169
+24.5%
0.00%
Q2 2018$804,000
+1118.2%
355,987
+1086.6%
0.00%
Q2 2017$66,00030,000
+68081.8%
0.00%
Q2 2016$0
-100.0%
44
-98.5%
0.00%
Q4 2015$3,0000.0%2,904
+16.2%
0.00%
Q3 2015$3,000
-85.7%
2,500
-80.0%
0.00%
Q2 2015$21,000
-83.3%
12,500
-85.8%
0.00%
Q1 2015$126,000
+6200.0%
87,767
+3410.7%
0.00%
Q4 2014$2,000
-91.7%
2,500
-88.8%
0.00%
Q3 2014$24,000
-89.9%
22,306
-83.0%
0.00%
Q2 2014$237,000
-63.3%
131,005
-69.7%
0.00%
Q1 2014$646,000
-35.8%
432,864
-21.4%
0.00%
-100.0%
Q4 2013$1,007,000
-47.1%
550,694
-40.4%
0.00%0.0%
Q3 2013$1,902,000923,8500.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Deer VI & Co. LLC 675,242$1,884,000100.00%
Prosight Management, LP 1,057,690$2,951,0002.17%
NEA Management Company, LLC 16,362,694$45,652,0001.89%
EMORY UNIVERSITY 602,883$1,682,0001.44%
New Leaf Venture Partners, L.L.C. 964,520$2,691,0001.26%
RA Capital Management 5,062,759$14,125,0001.18%
Avoro Capital Advisors LLC 4,006,893$11,179,0000.72%
683 Capital Management, LLC 2,500,000$6,975,0000.59%
X-Square Capital, LLC 199,345$557,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 1,300,000$3,627,0000.43%
View complete list of AVEO PHARMACEUTICALS INC shareholders